Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bioverge Ventures is a healthcare venture capital platform based in the United States, founded to democratize access to healthcare innovation. The firm manages a portfolio of 10 companies and invests across various stages, including seed, Series A, Series B, and growth equity.
Bioverge Ventures invests in diversified portfolios of healthcare startups, targeting sectors such as biotechnology, digital health, life sciences, and medical technology. Their investment vehicles include Access Funds, deal-by-deal opportunities, and thematic funds focused on specific technology or disease areas like longevity and cancer.
Notable portfolio companies include: Ancilia Biosciences, a CRISPR-based therapeutic company; Alto Neuroscience, which develops AI-driven precision medicine for psychiatric conditions; Aspen Neuroscience, focused on neuron replacement therapies for Parkinson's disease; Blue Mesa Health, a digital platform for diabetes prevention; and Bionaut Labs, which creates microscale robots for targeted therapy delivery.
Submit your pitch through their form at https://www.bioverge.com.
Bioverge Ventures typically participates in rounds but may lead depending on the opportunity and alignment with their investment thesis.
The firm is open to follow-on investments, especially in companies that demonstrate significant progress and alignment with their healthcare focus.
Specific fund size details are not disclosed, but the firm actively manages a portfolio of 10 companies across various healthcare sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.